Trial · NCT04397354
Intracochlear Dexamethasone Application During Cochlear Implantation for Preserving Cochlear Cells
NCT04397354, Not applicable, Completed, Pamukkale University
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Intracochlear Dexamethasone Application During Cochlear Implantation for Preserving Cochlear Cells. Trials, record NCT04397354. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT04397354
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Intracochlear Dexamethasone Application During Cochlear Implantation for Preserving Cochlear Cells
- NCT number
- NCT04397354
- Status
- Completed
- Phases
- Not applicable
- Enrollment
- 34 participants, actual
- Lead sponsor
- Pamukkale University
- Conditions
- Hearing Loss, Sensorineural
- Interventions
- Intracochlear Dexamethasone, Intratympanic Dexamethasone, No additional drugs(control Group)
- First posted
- 2020-05-21
- Last updated
- 2023-01-04
Source ClinicalTrials.gov
Registered outcomes2
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Electrode Impedance(Ohm) | 1-3 months | All intra-operative impedance values will be acquired after surgery. They will be repeated in first and 3 rd months |
| Primary | Electrode thresholds(CL) | 1-3 months | All intra-operative thresholds will be acquired after surgery. They will be repeated in first and 3 rd months |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT04397354
GET https://conductscience.org/api/trials/v1/NCT04397354/registered